Liquidia Technologies, Inc. (LQDA)


Liquidia Technologies, Inc. (LQDA)

$4.05 USD

0.08 (-1.94%)

Updated Sep 13 12:00am

Add LQDA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 216 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

LQDA Daily Price Range
LQDA 52-Week Price Range

LQDA Stock Chart More Charts


LQDA Price/Volume Stats

Current price $4.05
Prev. close $4.13
Day low $3.92
Day high $4.35
50-day MA $6.23
200-day MA $12.09
52-week high $38.46
52-week low $3.25
Volume 49,500
Avg. volume 90,401
Dividend yield N/A
Market Cap 75.50M

Liquidia Technologies, Inc. (LQDA) Company Bio


Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension. The company is also developing LIQ865, which completed Phase Ib clinical trials for the treatment of local post-operative pain. The company was founded in 2004 and is based in Morrisville, North Carolina.





LQDA News Stream


Event/Time News Detail
Loading, please wait...

LQDA Social Stream


Loading social stream, please wait...

View Full LQDA Social Stream

LQDA Returns

1-mo -32.39%
3-mo -53.34%
6-mo -73.37%
1-year -77.95%
3-year N/A
5-year N/A
YTD -81.30%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.0222 seconds.